CELLULARWOUND Trademark

Trademark Overview


On Monday, February 26, 2024, a trademark application was filed for CELLULARWOUND with the United States Patent and Trademark Office. The USPTO has given the CELLULARWOUND trademark a serial number of 98420476. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 19, 2024. The CELLULARWOUND trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in mesotherapy, esthetic, and pain management procedures; Medical apparatus for the treatment of wounds and ulcers; surgical and medical apparatus and instruments for use in dental, orthopedic, cosmetic, esthetic, and ophthalmological surgery; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; surgical instruments, namely, glass tubes for separating biological tissues; medical and surgical apparatus and instruments for use in general surgery; Surgical, medical and veterinary apparatus and instruments, including apparatus and instruments for autologous blood treatment, blood collection apparatus and instruments, apparatus and instruments for blood separation, apparatus and instruments for bone marrow separation, apparatus and instruments for...
cellularwound

General Information


Serial Number98420476
Word MarkCELLULARWOUND
Filing DateMonday, February 26, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCELLULAR WOUND
Goods and ServicesMedical apparatus and instruments for use in mesotherapy, esthetic, and pain management procedures; Medical apparatus for the treatment of wounds and ulcers; surgical and medical apparatus and instruments for use in dental, orthopedic, cosmetic, esthetic, and ophthalmological surgery; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; surgical instruments, namely, glass tubes for separating biological tissues; medical and surgical apparatus and instruments for use in general surgery; Surgical, medical and veterinary apparatus and instruments, including apparatus and instruments for autologous blood treatment, blood collection apparatus and instruments, apparatus and instruments for blood separation, apparatus and instruments for bone marrow separation, apparatus and instruments for centrifugation of blood, apparatus and instruments for filtering blood, and coagulation instruments; Surgical, medical and veterinary apparatus and instruments for the production of platelet rich plasma membranes, bone marrow concentrate, and platelet rich plasma in combination with hyaluronic acid

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressLauenen b. Gstaad 3782
CH

Trademark Events


Event DateEvent Description
Monday, February 26, 2024NEW APPLICATION ENTERED
Tuesday, July 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2024ASSIGNED TO EXAMINER
Thursday, September 19, 2024NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NON-FINAL ACTION WRITTEN
Thursday, September 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED